First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations
J Clin Oncol Sequist et al. 26:2248
Publisher's Note
The May 20, 2008, article by Sequist et al entitled, “First-Line Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Somatic EGFR Mutations” (J Clin Oncol 26:2442–2449, 2008) was published online May 5, 2008 with errors.
In the References section, reference 34a was inadvertently omitted, and should have been:
Cappuzzo F, Ligorio C, Janne PA, et al. Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial. J Clin Oncol 25:2248-2255, 2007.
Also, reference 35a was inadvertently omitted, and should have been:
Tokumo M, Toyooka S, Ichihara S, et al. Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer. Lung Cancer 53:117-121, 2006.
In the Discussion section, reference 34a should have been cited in the fourth sentence of the fourth paragraph instead of reference 22. In the fourth sentence of the fifth paragraph, reference 35a should have been cited instead of reference 27.
All corrections have been made as of June 30, 2008.
|
